3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
5
Neoplasm Metastasis
3
Carcinoma, Merkel Cell
3
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Gallbladder Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
fludarabine
3
aldesleukin
3
Specimen Handling
3
Fluorouracil
3
Cyclophosphamide
3
Bevacizumab
3
Sunitinib
2
Leucovorin
2
trastuzumab deruxtecan
1
sodium propionate
1
semaglutide
1
repotrectinib
1
patritumab deruxtecan
1
isosorbide-5-mononitrate
1
fludarabine phosphate
1
dehydroftorafur
1
Ultrasonography
1
Tretinoin
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Radiosurgery
1
Psilocybin
1
Positron-Emission Tomography
1
Photography
1
Pemetrexed
1
Pafolacianine
1
Oxaliplatin
1
Oviposition
1
Memantine
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
avelumab
×
30 days
×
Clear all
No trials found.